LY294002 and Rapamycin promote coxsackievirus-induced cytopathic effect and apoptosis via inhibition of PI3K/AKT/mTOR signaling pathway

Molecular and Cellular Biochemistry

Volumn 385, Issue 1-2, 2014, Pages 169-177

  Chen, Zhiheng ^a   Yang, Li ^a   Liu, Yong ^b   Tang, Anliu ^a   Li, Xin ^a   Zhang, Juan ^a   Yang, Zuocheng ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Apoptosis; Coxsackievirus induced cytopathic; LY294002; Rapamycin

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAPAMYCIN;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS B3; COXSACKIE VIRUS INFECTION; CYTOPATHOGENIC EFFECT; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; WESTERN BLOTTING;

APOPTOSIS; CHROMONES; COXSACKIEVIRUS INFECTIONS; CYTOPATHOGENIC EFFECT, VIRAL; ENTEROVIRUS; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; MORPHOLINES; PHOSPHATIDYLINOSITOL 3-KINASE; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SIROLIMUS; TOR SERINE-THREONINE KINASES;

EID: 84890515810     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1825-1     Document Type: Article

References (37)

1. Tracy S, Chapman NM, Romero J, Ramsingh AI (1996) Genetics of coxsackievirus B cardiovirulence and inflammatory heart muscle disease. Trends Microbiol 4:175-179
2. Esfandiarei M, McManus BM (2008) Molecular biology and pathogenesis of viral myocarditis. Annu Rev Pathol 3:127-155. doi: 10.1146/annurev.pathmechdis. 3.121806.151534
3. Liu P, Aitken K, Kong YY, Opavsky MA, Martino T, Dawood F, Wen WH, Kozieradzki I, Bachmaier K, Straus D, Mak TW, Penninger JM (2000) The tyrosine kinase p56lck is essential in coxsackievirus B3-mediated heart disease. Nat Med 6:429-434. doi: 10.1038/74689
4. Woodruff JF (1980) Viral myocarditis. A review. Am J Pathol 101:425-484
5. Whitton JL, Cornell CT, Feuer R (2005) Host and virus determinants of picornavirus pathogenesis and tropism. Nat Rev Microbiol 3:765-776. doi: 10.1038/nrmicro1284
6. Ahn J, Joo CH, Seo I, Kim D, Hong HN, Kim YK, Lee H (2003) Characteristics of apoptotic cell death induced by coxsackievirus B in permissive Vero cells. Intervirology 46:245-251
7. Maisch B, Ristic AD, Hufnagel G, Pankuweit S (2002) Pathophysiology of viral myocarditis: the role of humoral immune response. Cardiovasc Pathol 11:112-122
8. Tabor-Godwin JM, Ruller CM, Bagalso N, An N, Pagarigan RR, Harkins S, Gilbert PE, Kiosses WB, Gude NA, Cornell CT, Doran KS, Sussman MA, Whitton JL, Feuer R (2010) A novel population of myeloid cells responding to coxsackievirus infection assists in the dissemination of virus within the neonatal CNS. J Neurosci 30:8676-8691. doi: 10.1523/JNEUROSCI.1860-10.2010
9. Luo H, Yanagawa B, Zhang J, Luo Z, Zhang M, Esfandiarei M, Carthy C, Wilson JE, Yang D, McManus BM (2002) Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway. J Virol 76:3365-3373
10. Taylor LA, Carthy CM, Yang D, Saad K, Wong D, Schreiner G, Stanton LW, McManus BM (2000) Host gene regulation during coxsackievirus B3 infection in mice: assessment by microarrays. Circ Res 87:328-334
11. Kim KH, Min YK, Baik JH, Lau LF, Chaqour B, Chung KC (2003) Expression of angiogenic factor Cyr61 during neuronal cell death via the activation of c-Jun N-terminal kinase and serum response factor. J Biol Chem 278:13847-13854. doi: 10.1074/jbc.M210128200
12. Yuan JP, Zhao W, Wang HT, Wu KY, Li T, Guo XK, Tong SQ (2003) Coxsackievirus B3-induced apoptosis and caspase-3. Cell Res 13:203-209. doi: 10.1038/sj.cr.7290165
13. Opavsky MA, Martino T, Rabinovitch M, Penninger J, Richardson C, Petric M, Trinidad C, Butcher L, Chan J, Liu PP (2002) Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis. J Clin Invest 109:1561-1569. doi: 10.1172/JCI13971
14. Esfandiarei M, Luo H, Yanagawa B, Suarez A, Dabiri D, Zhang J, McManus BM (2004) Protein kinase B/Akt regulates coxsackievirus B3 replication through a mechanism which is not caspase dependent. J Virol 78:4289-4298
15. Ferte C, Andre F, Soria JC (2010) Molecular circuits of solid tumors: prognostic and predictive tools for bedside use. Nat Rev Clin Oncol 7:367-380. doi: 10.1038/nrclinonc.2010.84
16. Laplante M, Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149:274-293. doi: 10.1016/j.cell.2012.03.017
17. Dobbin ZC, Landen CN (2013) The importance of the PI3K/AKT/MTOR pathway in the progression of ovarian cancer. Int J Mol Sci 14:8213-8227. doi: 10.3390/ijms14048213
18. Martini M, Ciraolo E, Gulluni F, Hirsch E (2013) Targeting PI3K in cancer: any good news? Front Oncol 3:108. doi: 10.3389/fonc.2013.00108
19. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307:1098-1101. doi: 10.1126/science.1106148
20. Franke TF, Cantley LC (1997) Apoptosis. A bad kinase makes good. Nature 390:116-117. doi: 10.1038/36442
21. Populo H, Lopes JM, Soares P (2012) The mTOR signalling pathway in human cancer. Int J Mol Sci 13:1886-1918. doi: 10.3390/ijms13021886
22. Chapuis N, Tamburini J, Green AS, Willems L, Bardet V, Park S, Lacombe C, Mayeux P, Bouscary D (2010) Perspectives on inhibiting mTOR as a future treatment strategy for hematological malignancies. Leukemia 24:1686-1699. doi: 10.1038/leu.2010.170
23. Virbasius JV, Guilherme A, Czech MP (1996) Mouse p170 is a novel phosphatidylinositol 3-kinase containing a C2 domain. J Biol Chem 271:13304-13307
24. Karam AK, Santiskulvong C, Fekete M, Zabih S, Eng C, Dorigo O (2010) Cisplatin and PI3kinase inhibition decrease invasion and migration of human ovarian carcinoma cells and regulate matrix-metalloproteinase expression. Cytoskeleton (Hoboken) 67:535-544. doi: 10.1002/cm.20465
25. Henke A, Launhardt H, Klement K, Stelzner A, Zell R, Munder T (2000) Apoptosis in coxsackievirus B3-caused diseases: interaction between the capsid protein VP2 and the proapoptotic protein Siva. J Virol 74:4284-4290
26. Peng T, Sadusky T, Li Y, Coulton GR, Zhang H, Archard LC (2001) Altered expression of Bag-1 in coxsackievirus B3 infected mouse heart. Cardiovasc Res 50:46-55
27. Kim SM, Park JH, Chung SK, Kim JY, Hwang HY, Chung KC, Jo I, Park SI, Nam JH (2004) Coxsackievirus B3 infection induces cyr61 activation via JNK to mediate cell death. J Virol 78:13479-13488. doi: 10.1128/JVI.78.24.13479-13488. 2004
28. Esfandiarei M, Suarez A, Amaral A, Si X, Rahmani M, Dedhar S, McManus BM (2006) Novel role for integrin-linked kinase in modulation of coxsackievirus B3 replication and virus-induced cardiomyocyte injury. Circ Res 99:354-361. doi: 10.1161/01.RES.0000237022.72726.01
29. Tan J, Yu Q (2013) Molecular mechanisms of tumor resistance to PI3K-mTOR targeted cancer therapy. Chin J Cancer. doi: 10.5732/cjc.012.10287
30. Sheppard K, Kinross KM, Solomon B, Pearson RB, Phillips WA (2012) Targeting PI3 kinase/AKT/mTOR signaling in cancer. Crit Rev Oncog 17:69-95
31. Cantley LC (2002) The phosphoinositide 3-kinase pathway. Science 296:1655-1657. doi: 10.1126/science.296.5573.1655
32. Markman B, Dienstmann R, Tabernero J (2010) Targeting the PI3K/Akt/mTOR pathway-beyond rapalogs. Oncotarget 1:530-543
33. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857-868
34. Diehl JA, Cheng M, Roussel MF, Sherr CJ (1998) Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12:3499-3511
35. Cerniglia GJ, Karar J, Tyagi S, Christofidou-Solomidou M, Rengan R, Koumenis C, Maity A (2012) Inhibition of autophagy as a strategy to augment radiosensitization by the dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235. Mol Pharmacol 82:1230-1240. doi: 10.1124/mol.112.080408
36. Meng Q, Xia C, Fang J, Rojanasakul Y, Jiang BH (2006) Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway. Cell Signal 18:2262-2271. doi: 10.1016/j.cellsig.2006.05.019
37. Carden CP, Stewart A, Thavasu P, Kipps E, Pope L, Crespo M, Miranda S, Attard G, Garrett MD, Clarke PA, Workman P, de Bono JS, Gore M, Kaye SB, Banerji U (2012) The association of PI3 kinase signaling and chemoresistance in advanced ovarian cancer. Mol Cancer Ther 11:1609-1617. doi: 10.1158/1535-7163. MCT-11-0996